Stockscreener 앱 받기
8.66
2.70%
-0.24
Vir Biotechnology Inc 주식(VIR)의 최신 뉴스
Eversept Partners LP Takes $2.24 Million Position in Vir Biotechnology, Inc. $VIR - MarketBeat
Empyrean Capital Partners LP Invests $4.73 Million in Vir Biotechnology, Inc. $VIR - MarketBeat
Vir Biotechnology, Inc. (VIR) Q1 2026 Earnings ReportResults, Call & Slides - TipRanks
Avoiding Lag: Real-Time Signals in (VIR) Movement - Stock Traders Daily
Vir Biotechnology, Inc. Revenue Breakdown – NASDAQ:VIR - TradingView
Vir Biotechnology Appoints Brent Sabatini as Interim Principal Financial Officer - Moomoo
Vir Biotechnology, Inc. (VIR) Q4 2023 Earnings ReportResults, Call & Slides - TipRanks
Vir Biotechnology Names Brent Sabatini Interim Finance Chief - The Globe and Mail
Vir Biotechnology, Inc. (VIR) Q1 2024 Earnings ReportResults, Call & Slides - TipRanks
Vir Biotechnology Inc (VIR) Income Statement - TradingKey
Vir Biotechnology, Inc. (VIR) Q4 2025 Earnings ReportResults, Call & Slides - TipRanks
VIR|Vir Biotechnology Inc|Price:8.800|Chg%:+0.110 - TradingKey
Vir Biotechnology Inc (VIR) Cash Flow - TradingKey
Vir Biotechnology Appoints Interim CFO Amid Transition - Intellectia AI
Vir Biotechnology Inc (VIR) Institutional Confidence - TradingKey
Vir Biotechnology Inc (VIR) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Vir Biotechnology Inc (VIR) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Vir Biotechnology Inc (VIR) Valuation: PE, PB & Fair Value Analysis - TradingKey
Vir Biotechnology Inc (VIR) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Vir Biotechnology Inc (VIR) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Vir Biotechnology (VIR) Appoints Interim Financial Officer Amid Leadership Changes - GuruFocus
Vir Biotechnology Inc (VIR) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Vir Biotechnology Inc (VIR) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Vir Biotechnology Inc (VIR) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Vir Biotechnology Inc (VIR) Balance Sheet - TradingKey
VIR|Vir Biotechnology Inc|Price:8.690|Chg%:-0.650 - TradingKey
Vir Biotechnology: Sabatini Has Served as Senior Vice Pres and Chief Acctg Officer Since Feb 2023 >VIR - Moomoo
Why is Vir Biotechnology stock sliding today? - Investing.com
Why is Vir Biotechnology stock sliding today? By Investing.com - Investing.com Canada
Vir Biotechnology (VIR) Announces New Interim Financial Leadersh - GuruFocus
Vir Biotechnology (NASDAQ:VIR) Shares Gap DownWhat's Next? - MarketBeat
Vir Biotechnology stock falls as CFO O’Byrne departs By Investing.com - Investing.com India
Vir Biotechnology stock falls as CFO O’Byrne departs - Investing.com
Vir Biotechnology Announces Chief Financial Officer Transition - BioSpace
Vir Biotechnology, Inc. Announces Resignation of Jason O'Byrne as Executive Vice President, Effective August 3, 2026 - marketscreener.com
Vir Biotechnology Appoints Brent Sabatini as Interim CFO Following Jason O'Byrne's Resignation - Kalkine Media
Vir Biotechnology names interim finance chief - Investing.com
Vir Biotechnology (VIR) TD Cowen 46th Annual Health Care Conference Summary - Quartr
Vir Biotechnology Financial Chief to Depart - Moomoo
Vir Biotechnology names interim finance chief By Investing.com - Investing.com Canada
Vir Biotechnology (VIR) Short Interest & Short Float | Updated Jul 2026 $VIR - MarketBeat
VIR Q2'26 Earnings: revenue estimate is 135.88M USD - TradingView
Vir Biotechnology to Host Conference Call for Second Quarter 2026 Financial Results - BioSpace
Vir Biotechnology to host conference call for Q2 2026 results - scanx.trade
VIR Stock Surges 60% Pre-Market Today – Analysts Cheer Strong Cancer Data, Astellas Partnership - Stocktwits
Vir Biotechnology, Inc. (NASDAQ:VIR) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Vir Biotechnology (VIR) Bank of America Global Healthcare Conference 2026 Summary - Quartr
VIR stock reacts to latest clinical updates and cash position - Ad-hoc-news.de
Why Did Vir Biotechnology Stock Surge 60% After-Hours Today? - Stocktwits
Vir Biotechnology nears key trial results in he... - Pluang
Vir Biotechnology: Multiple Catalysts In Hepatitis And Oncology Ahead (NASDAQ:VIR) - Seeking Alpha
Hillsdale Investment Management Inc. Invests $1.44 Million in Vir Biotechnology, Inc. $VIR - MarketBeat
Discipline and Rules-Based Execution in VIR Response - Stock Traders Daily
Vir Biotechnology, Inc. $VIR Shares Bought by Candriam S.C.A. - MarketBeat
Y Intercept Hong Kong Ltd Takes Position in Vir Biotechnology, Inc. $VIR - MarketBeat
Vir Biotechnology (VIR) BofA Securities 2025 Healthcare Conference Summary - Quartr
2.44%
0.02%
자본화:
|
볼륨(24시간):